Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Brexpiprazole in Chinese Healthy Subjects
NCT03734302Phase 1Completed
- Sponsor
- Otsuka Holdings
- Start
- Apr 2019
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of brexpiprazole orally disintegrating tablet, sponsored by Otsuka Holdings. Primary endpoints: Steady-state peak time at Day 14, Steady-state valley concentration at Day 14 and 12 more. Started Apr 2019; status: completed.
02
Drugs
brexpiprazole orally disintegrating tablet
Beyond the preview
Go deeper on NCT03734302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03734302.